Pharmaceutical companies by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Travere Therapeutics leads the 39 pharmaceutical companies ranked by P/B ratio, at 213, ahead of Arrowhead Pharmaceuticals (121) and Rhythm Pharmaceuticals (93.8). Figures as of 18 Nov 2026, 23:15 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
39
First
Travere Therapeutics213
Median
6.8
Combined market value
NZ$9.21T
Countries
10
Not ranked
22no P/B ratio on file

Market values as of .

All countries
All sectors
Pharmaceuticals
NZD
Clear filters
Pharmaceutical companies by P/B ratio
#CompanyP/B ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Travere TherapeuticsTVTX · Health Care213NZ$8.8BNZ$91.51 1.68% down 44% up United States
2Arrowhead PharmaceuticalsARWR · Health Care121NZ$11.1BNZ$78.52 0.28% up 10% up United States
3Rhythm PharmaceuticalsRYTM · Health Care93.8NZ$15BNZ$216.83 2.08% up 13% up United States
4Axsome TherapeuticsAXSM · Health Care66.8NZ$12.8BNZ$244.08 1.43% down 7% down United States
5InsmedINSM · Health Care36.2NZ$47.9BNZ$218.22 1.69% down 40% down United States
6Eli LillyLLY · Health Care30.6NZ$2.24TNZ$2,518.68 2.32% down 35% up United States
7TG TherapeuticsTGTX · Health Care16.2NZ$18.2BNZ$120.44 5.44% up 107% up United States
8Summit TherapeuticsSMMT · Health Care14.9NZ$15.3BNZ$19.13 1.59% down 36% down United States
9Madrigal PharmaceuticalsMDGL · Health Care14.7NZ$16.8BNZ$725.10 5.67% down 24% down United States
10Amneal PharmaceuticalsAMRX · Health Care14.3NZ$13.9BNZ$39.85 3.60% up 83% up United States
11Ionis PharmaceuticalsIONS · Health Care11.6NZ$8.3BNZ$49.89 1.59% up 64% down United States
12Cogent BiosciencesCOGT · Health Care10.7NZ$8.8BNZ$50.66 0.14% down 20% down United States
13ZoetisZTS · Health Care10.6NZ$63.3BNZ$155.87 2.50% up 29% down United States
14Spyre TherapeuticsSYRE · Health Care10.1NZ$17.6BNZ$184.81 8.15% up 286% up United States
15Corcept TherapeuticsCORT · Health Care8.9NZ$13.5BNZ$123.48 3.25% down 8% down United States
16Johnson & JohnsonJNJ · Health Care8.1NZ$1.2TNZ$496.72 2.15% down 38% up United States
17Belite BioBLTE · Health Care8.0NZ$11.6BNZ$284.57 0.94% down 31% up United States
18Protagonist TherapeuticsPTGX · Health Care7.6NZ$15.1BNZ$231.62 2.00% up 46% up United States
19Merck & CoMRK · Health Care7.6NZ$618.7BNZ$250.97 3.90% down 51% up United States
20Praxis Precision MedicinesPRAX · Health Care6.8NZ$15.5BNZ$555.90 0.04% up 61% up United States
21VeradermicsMANE · Health Care6.6NZ$9.6BNZ$227.43 0.62% down 233% up United States
22Vertex PharmaceuticalsVRTX · Health Care6.5NZ$247.7BNZ$977.14 0.42% up 27% up United States
23Ligand PharmaceuticalsLGND · Health Care6.2NZ$10.9BNZ$544.10 1.67% up 43% up United States
24Alnylam PharmaceuticalsALNY · Health Care5.5NZ$36.4BNZ$272.13 4.54% down 66% down United States
25Oruka TherapeuticsORKA · Health Care5.4NZ$11.8BNZ$174.39 0.60% down 241% up United States
26ErascaERAS · Health Care5.3NZ$8.8BNZ$25.06 0.94% down 403% up United States
27Bristol-Myers SquibbBMY · Health Care5.2NZ$221.8BNZ$108.49 2.92% down 34% up United States
28Royalty PharmaRPRX · Health Care4.5NZ$71.9BNZ$125.08 0.01% down 78% up United States
29Definium TherapeuticsDFTX · Health Care4.1NZ$7.3BNZ$53.04 0.88% down 169% up United States
30United TherapeuticsUTHR · Health Care3.9NZ$44.8BNZ$1,051.62 1.16% down 23% up United States
31Dianthus TherapeuticsDNTH · Health Care3.8NZ$8.6BNZ$152.97 3.45% down 113% up United States
32Abbott LaboratoriesABT · Health Care3.5NZ$329.6BNZ$190.31 0.22% down 17% down United States
33Regeneron PharmaceuticalsREGN · Health Care2.8NZ$178.2BNZ$1,722.28 1.28% down 36% up United States
34Edgewise TherapeuticsEWTX · Health Care2.8NZ$8.3BNZ$75.36 1.59% down 88% up United States
35Legend BiotechLEGN · Health Care2.5NZ$5.7BNZ$29.60 0.87% up 42% down United States
36Elanco Animal HealthELAN · Health Care2.0NZ$24.3BNZ$48.63 3.29% up 20% up United States
37BioMarin PharmaceuticalBMRN · Health Care1.9NZ$21.7BNZ$111.89 4.99% up 11% up United States
38PfizerPFE · Health Care1.8NZ$291.3BNZ$51.11 1.44% down 14% up United States
39ViatrisVTRS · Health Care1.7NZ$42.4BNZ$36.94 0.83% down 96% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8215 NZD). 22 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies rank first by P/B ratio?

Travere Therapeutics (213), Arrowhead Pharmaceuticals (121) and Rhythm Pharmaceuticals (93.8) are the top three of the 39 pharmaceutical companies ranked by P/B ratio as of 18 Nov 2026, 23:15 UTC.

How many pharmaceutical companies are in this ranking?

39 are ranked by P/B ratio. 22 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies worth together?

The 39 pharmaceutical companies ranked by P/B ratio have a combined market value of NZ$9.21T as of 18 Nov 2026, 23:15 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Pharmaceutical companies by P/B ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.